The psychoimmunology of Lyme/tick-borne diseases and its association with neuropsychiatric symptoms

Open Neurology Journal

Volumn 6, Issue SPEC.ISS.1, 2012, Pages 88-93

  Bransfield, Robert C ^a  

^a NONE   (United States)

Author keywords

Immune; Inflammation; Lyme; Mental; Psychiatric; Tick borne

Indexed keywords

CXCL13 CHEMOKINE; GAMMA INTERFERON; HOMOCYSTEINE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR; TRYPTOPHAN; TUMOR NECROSIS FACTOR;

ARTICLE; AUTISM; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BORRELIA BURGDORFERI; DEMENTIA; DEPRESSION; EPILEPSY; EXCITOTOXICITY; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; IMPULSIVENESS; INFLAMMATION; LYME DISEASE; MENTAL DISEASE; META ANALYSIS (TOPIC); MICROORGANISM; MOLECULAR MIMICRY; NEUROPSYCHIATRY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOIMMUNOLOGY; PSYCHOSIS; SICKNESS SYNDROME; TICK BORNE DISEASE;

EID: 84867687655     PISSN: None     EISSN: 1874205X     Source Type: Journal    
DOI: 10.2174/1874205X01206010088     Document Type: Article

References (64)

1. Miklossy J. Alzheimer's disease - a neurospirochetosis. analysis of the evidence following Koch's and Hill's criteria. J Neuroinflamma-tion 2011; 8: 90.
2. Brown AS, Patterson PH. Maternal infection and schizophrenia: implications for prevention. Schizophr Bull 2011; 37: 284-290.
3. Ling VJ, Lester D, Mortensen PB, Langenberg PW, Postolache TT. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 2011; 199:440-444.
4. Mortensen CR, Becker DV, Ackerman JM, Neuberg SL, Kenrick DT. Infection breeds reticence: the effects of disease salience on self-perceptions of personality and behavioral avoidance tendencies. Psychol Sci 2010; 21: 440-447.
5. Bransfield RC. Preventable cases of autism: relationship between chronic infectious diseases and neurological outcome Ped Health 2009; 3: 125-140.
6. Bransfield RC, Wulfman JS, Harvey WT, Usman AI. The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders Med Hypotheses 2008; 70: 967-974.
7. Träskman-Bendz L, Westling S. The psychobiology of aggressive behaviour. Adv Health Econ Health Serv Res 2005; 16: 3-14.
8. Knuesel I. Prenatal infection as driving force of aging-associated neurodegenerative diseases. Praxis (Bern 1994) 2011; 100: 299-304.
9. Daneman R, Rescigno M. The gut immune barrier and the blood-brain barrier: are they so different? Immunity 2009; 31: 722-735.
10. Kalinchuk AV, McCarley RW, Porkka-Heiskanen T, Basheer R. Sleep deprivation triggers inducible nitric oxide-dependent nitric oxide production in wake-active basal forebrain neurons. J Neuro-sci 2010; 30: 13254-13264.
11. Gardner RM, Nyland JF, Silbergeld EK. Differential immunotoxic effects of inorganic and organic mercury species in vitro. Toxicol Lett 2010; 198: 182-190.
12. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011; 283: 65-87.
13. Aldabal L, Bahammam AS. Metabolic, endocrine, and immune consequences of sleep deprivation. Open Respir Med J 2011; 5: 31-43.
14. Kristensson K. Microbes' roadmap to neurons. Nat Rev Neurosci 2011; 12: 345-357.
15. nd International Lyme and associated diseases society European meeting, Augsburg, Germany; May, 2011
16. Chervonsky AV. Influence of microbial environment on autoim-munity. Nat Immunol 2010; 11: 28-35.
17. Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM. Toll-like receptors in inflammation, infection and cancer. Int Im-munopharmacol 2007; 7: 1271-1285.
18. Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depressioninduced by high-dose interferon alfa. N Engl J Med 2001; 344: 961-966.
19. Constant A, Castera L, Dantzer R, et al. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic anddepressive symptoms. J Clin Psychiatry 2005; 66: 1050-1057.
20. Hong BA, North CS, Pollio DE, et al. The use of psychoeducation for a patient with hepatitis C and psychiatric illness in preparation for antiviral therapy: a case report and discussion. J Clin Psychol Med Settings 2011; 18: 99-107.
21. Greenberg HE, Ney G, Scharf SM, Ravdin L, Hilton E. Sleep quality in Lyme disease. Sleep 1995; 18: 912-916.
22. Moldofsky H. Sleep and the immune system. Int J Immunopharma-col 1995; 17: 649-654.
23. Lorton D, Lubahn CL, Estus C, et al. Bidirectional communication between the brain and the immune system: implicationsfor physiological sleep and disorders with disrupted sleep. Neuroimmuno-modulation 2006; 13: 357-374.
24. Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007; 30: 1145-1152.
25. Kelley KW. The role of growth hormone in modulation of the immune response. Ann N Y Acad Sci. 1990; 594: 95-103.
26. Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol 2011; 7(9): 518-527.
27. Gao HM, Hong JS. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 2008; 29: 357-365.
28. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-457.
29. Swardfager W, Lanctôt K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 2010; 68: 930-941.
30. Tatiana Falcone T, Carlton E, Franco K, Janigro D. Inflammation, psychosis, and the brain. Psychiatr Times 2009; 26.
31. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011;7: 31-40.
32. Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med 2011; 208: 417-420.
33. Bleich S, Degner D, Sperling W, Bönsch D, Thürauf N, Kornhuber J. Homocysteine as a neurotoxin in chronic alcoholism. Prog Neu-ropsychopharmacol Biol Psychiatry 2004; 28: 453-464.
34. Wersching H, Duning T, Lohmann H, et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology 2010; 74: 1022-1029.
35. Lindqvist D, Janelidze S, Hagell P, et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 2009; 66: 287-292.
36. Westling S, Ahrén B, Träskman-Bendz L, Brundin L. Increased IL-1β reactivity upon a glucose challenge in patients with deliberate self-harm. Acta Psychiatr Scand 2011; 124(4): 301-306.
37. Corwin EJ, Bozoky I, Pugh LC, Johnston N. Interleukin-1beta elevation during the postpartum period. Ann Behav Med. 2003; 25: 41-47.
38. Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA. Interleukin-1receptor activation by systemic lipopolysaccha-ride induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 2010; 35: 2510-2520.
39. Sergiev VP. Change of host's behavior including man under the influence of parasites. Zh Mikrobiol Epidemiol Immunobiol 2010; 3: 108-114.
40. Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry 2005; 10: 538-544.
41. Halperin JJ, Heyes MP. Neuroactive kynurenines in Lyme borrelio-sis. Neurology 1992; 42: 43-50.
42. Newell MK, Tobin RP, Cabrera JH, et al. TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation. J Leukoc Biol 2010; 88: 779-789.
43. Fallon BA, Levin ES, Schweitzer PJ, Hardesty D. Inflammation and central nervous system Lyme disease. Neurobiol Dis 2010; 37: 534-541.
44. Weller M, Stevens A, Sommer N, Wiethölter H, Dichgans J. Cere-brospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis. Arch Neurol 1991; 48: 837-841.
45. Pachner AR, Amemiya K, Delaney E, O'Neill T, Hughes CA, Zhang WF. Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology 1997; 49: 147-152.
46. Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation 2009; 6: 42.
47. Wutte N, Berghold A, Loffler S, et al. CXCL13 chemokine in pediatric and adult neuroborreliosis. Acta Neurol Scand 2011 124(5): 321-328.
48. Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. J Infect 2011; 62: 149-158.
49. Maloy AL, Black RD, Segurola RJ Jr. Lyme disease complicated by the Jarisch-Herxheimer reaction. J Emerg Med 1998; 16: 437-438.
50. Andreasen N, Blennow K, Zetterberg H. Neuroinflammation screening in immunotherapy trials against Alzheimer's disease. Int J Alzheimers Dis 2010; 2010: 638379.
51. Schutzer SE, Angel TE, Liu T, et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One 2011; 6: e17287.
52. Kayser MS, Dalmau J. Psychiatric Presentations of Autoimmune Encephalopathies. Psychiatr Times 2010; 27.
53. Moscato EH, Jain A, Peng X, Hughes EG, Dalmau J, Balice-Gordon RJ. Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neuro-sci 2010; 32: 298-309.
54. Schneider RK, Robinson MJ, Levenson JL. Psychiatric presentations of non-HIV infectious diseases. Neurocysticercosis, Lyme disease, and pediatric autoimmune neuropsychiatric disorder asso-ciated with streptococcal infection. Psychiatr Clin North Am 2002; 25: 1-16.
55. Ercan TE, Ercan G, Severge B, Arpaozu M, Karasu G. My-coplasma pneumoniae infection and obsessive-compulsive disease: a case report. J Child Neurol 2008; 23: 338-340.
56. Leah E. Neuropsychiatric disorders: Neurons excited to death by SLE autoantibodies. Nat Rev Rheumatol 2011; 7: 1.
57. Chandra A, Wormser GP, Klempner MS, et al. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun 2010; 24: 1018-1024.
58. Hassett AL, Radvanski DC, Buyske S, Savage SV, Sigal LH. Psychiatric comorbidity and other psychological factors in patients with chronic Lyme disease. Am J Med 2009; 122: 843-850.
59. Stricker RB, Johnson L. Letter to the editor re Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms by Chandra et al. Brain Behav Immun. 2010; 24:1025; author reply 1026.
60. Nicolson GL, Gan R, Nicolson NL, Haier J. Evidence for My-coplasma, Chlamydia pneunomiae and HHV-6 co-infections in the blood of patients with autism spectrum disorders. J Neurosci Res 2007; 85: 1143-1148.
61. Nicholson G. Chronic bacterial and viral infections in neurodegen-erative and neurobehavioral diseases. Lab Med 2008; 39: 291-299.
62. Goines P, Van de Water J. The immune system's role in the biology of autism. Curr Opin Neurol 2010; 23: 111-117.
63. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through inter-leukin-6. J Neurosci 2007; 27: 10695-10702.
64. Martin LA, Ashwood P, Braunschweig D, Cabanlit M, Van de Water J, Amaral DG. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun 2008; 22: 806-816.